Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

540 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-07-31

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the prevalence of Fabry mutations in patients with left ventricular hypertrophy (moderate to severe), as measured by echocardiography.This study is a screening study

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography

NCT02221141

Left Ventricular Hypertrophy

COMPLETED

Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy

NCT06169358

Hypertrophic Cardiomyopathy Left Ventricular Hypertrophy Fabry Disease

UNKNOWN

Viennese Prevalence Study of Anderson-Fabry Disease

NCT00871611

Fabry Disease Left Ventricular Hypertrophy

UNKNOWN

Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score

NCT04943991

Fabry Disease Fabry Disease, Cardiac Variant Lysosomal Storage Diseases +2 more

ACTIVE_NOT_RECRUITING NA

Anderson Fabry Disease - the Power of Information.

NCT07136662

Fabry Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Left Ventricular Hypertrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

left ventricular hypertrophy

Patients with left ventricular hypertrophy will be used.

blood sampling

Intervention Type OTHER

Blood sampling will be used.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood sampling

Blood sampling will be used.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients over 18 years undergoing a routine echocardiography in the participating hospitals
* Both genders will be considered.
* Patients can be included if on 2D echocardiography the maximal septal wall thickness \> 13 mm and/or the posterior wall thickness \> 13 mm. The limit for inclusion is kept relatively low to detect early forms of Fabry cardiomyopathy.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No